Clinical Trials Browser

Phase 1/2 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × palmitoyl-L-asparaginase × Clear all

NCT00098839 2017-12-12

Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

Phase 1/2 Completed

134 enrolled 13 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma